Muryel Vary, PA
Physician Assistant · New Bern, NCNPI 1881086742
Payments from drug & device makers
Across 264 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$874
- Lilly USA, LLC$474
- Abbott$341
- AbbVie$310
- GSK$294
- Axsome Therapeutics, Inc.$224
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,315100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 58 | $874 |
| Lilly USA, LLC | 28 | $474 |
| Abbott | 23 | $341 |
| AbbVie | 16 | $310 |
| GSK | 20 | $294 |
| Axsome Therapeutics, Inc. | 13 | $224 |
| Otsuka America Pharmaceutical, Inc. | 9 | $191 |
| Amgen | 11 | $169 |
| Pfizer | 12 | $154 |
| Boehringer Ingelheim | 9 | $154 |
| Bayer | 8 | $145 |
| Merck | 7 | $134 |
| Mylan Specialty L.p. | 6 | $95 |
| Sanofi-aventis U.S. LLC | 5 | $90 |
| AstraZeneca | 5 | $89 |
| Ironwood Pharmaceuticals, Inc | 4 | $70 |
| Exact Sciences | 4 | $60 |
| Azurity Pharmaceuticals, Inc. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Medtronic | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Radius Health, Inc. | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Dexcom, Inc. | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Lundbeck LLC | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Genentech USA, Inc. | 1 | $4 |
How this compares
$4,315 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 51 | $63,705 |
| EliquisApixaban | 34 | $36,899 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $33,160 |
| JardianceEmpagliflozin | 18 | $28,556 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 18 | $16,240 |
| MyrbetriqMirabegron | 17 | $16,201 |
| FarxigaDapagliflozin Propanediol | 17 | $15,259 |
| RybelsusSemaglutide | 11 | $14,329 |
| OzempicSemaglutide | 11 | $14,248 |
| XareltoRivaroxaban | 18 | $12,206 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $8,245 |
| SynjardyEmpagliflozin/Metformin Hcl | 12 | $7,456 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 22 | $4,891 |
| Levothyroxine Sodium | 157 | $2,250 |
| Humalog Kwikpen U-100Insulin Lispro | 15 | $2,209 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $474 | $63,70551 claims |
| GSKTrelegy Ellipta, Shingrix | $294 | $38,05151 claims |
| PfizerEliquis | $154 | $36,89934 claims |
| Boehringer IngelheimJardiance, Synjardy | $154 | $36,01130 claims |
| Novo NordiskRybelsus, Ozempic | $874 | $28,57722 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $90 | $16,24018 claims |
| Astellas Pharma US IncMyrbetriq | $16 | $16,20117 claims |
| AstraZenecaFarxiga | $89 | $15,25917 claims |
| AbbVieSynthroid | $310 | $80923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in New Bern
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.